Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study
Verena Schönau(Friedrich-Alexander-Universität Erlangen-Nürnberg), Francesco Muratore(Azienda Sanitaria Unità Locale di Reggio Emilia), Luigi Boiardi, Carlo Salvarani(Sorbonne Université), Annibale Versari(Azienda Sanitaria Unità Locale di Reggio Emilia), Jürgen Rech(Universitätsklinikum Erlangen), Koray Taşçılar(Friedrich-Alexander-Universität Erlangen-Nürnberg), Jessica Roth, Giulia Corte(Friedrich-Alexander-Universität Erlangen-Nürnberg), Filippo Crescentini, Massimiliano Casali(Broad Institute), Georg Schett(Karolinska University Hospital), Torsten Kuwert(Friedrich-Alexander-Universität Erlangen-Nürnberg), Michael Uder(SUNY Upstate Medical University), Alexander Cavallaro(Friedrich-Alexander-Universität Erlangen-Nürnberg), Daniela Schmidt, Lucia Spaggiari(Azienda Sanitaria Unità Locale di Reggio Emilia), Bernhard Manger(Universitätsklinikum Erlangen), Elena Galli(Fatebenefratelli Hospital)
Cited by 68
Related Papers
2018 update of the EULAR recommendations for the management of Behçet's syndrome
|Annals of the Rheumatic Diseases|2018|771
EULAR recommendations for the management of Behçet disease
|Annals of the Rheumatic Diseases|2008|721
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
|Journal of Clinical Investigation|2012|708
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
|Frontiers in Pharmacology|2019|616
EULAR definition of difficult-to-treat rheumatoid arthritis
|Annals of the Rheumatic Diseases|2020|538